The global market for Contract Research Organization Services (CROs) is estimated at US$73.2 Billion in 2023 and is projected to reach US$149.1 Billion by 2030, growing at a CAGR of 10.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the CRO market is driven by several factors. The increasing complexity and cost of drug development are prompting pharmaceutical and biotechnology companies to outsource research activities to CROs. Technological advancements in data management and analytics are enhancing the capabilities and efficiency of CRO services. The globalization of clinical trials and the need to meet diverse regulatory requirements are also boosting demand for CROs with international expertise. Additionally, the rise of personalized medicine and the development of biologics and advanced therapies are creating new opportunities for CROs specializing in these areas. These factors collectively ensure the continued growth and innovation in the CRO market.
The growth in the CRO market is driven by several factors. The increasing complexity and cost of drug development are prompting pharmaceutical and biotechnology companies to outsource research activities to CROs. Technological advancements in data management and analytics are enhancing the capabilities and efficiency of CRO services. The globalization of clinical trials and the need to meet diverse regulatory requirements are also boosting demand for CROs with international expertise. Additionally, the rise of personalized medicine and the development of biologics and advanced therapies are creating new opportunities for CROs specializing in these areas. These factors collectively ensure the continued growth and innovation in the CRO market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Clinical Research Services segment, which is expected to reach US$76.7 Billion by 2030 with a CAGR of a 11.5%. The Early Phase Development Services segment is also set to grow at 10.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $29.2 Billion in 2023, and China, forecasted to grow at an impressive 13.5% CAGR to reach $10.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Contract Research Organization Services (CROs) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Contract Research Organization Services (CROs) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Contract Research Organization Services (CROs) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 360biolabs®, Charles River Laboratories International Inc., ICON plc, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 307 Featured):
- 360biolabs®
- Charles River Laboratories International Inc.
- ICON plc
- IQVIA, Inc.
- KCR S.A
- Medpace Holdings, Inc.
- Parexel International Corporation
- PSI CRO AG
- Syneos Health, Inc.
- WuXi AppTec
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPEREST OF ASIA-PACIFICREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
INDIA
LATIN AMERICA
Companies Mentioned
- 360biolabs®
- Charles River Laboratories International Inc.
- ICON plc
- IQVIA, Inc.
- KCR S.A
- Medpace Holdings, Inc.
- Parexel International Corporation
- PSI CRO AG
- Syneos Health, Inc.
- WuXi AppTec
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 803 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 73.2 Billion |
Forecasted Market Value ( USD | $ 149.1 Billion |
Compound Annual Growth Rate | 10.7% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |